Drooling treatment shows promise in Late-Stage trial
NCT ID NCT01994109
First seen Apr 24, 2026 · Last updated May 12, 2026 · Updated 4 times
Summary
This study tested an injected medication called MYOBLOC to reduce troublesome drooling in 187 adults. Drooling can be a side effect of many health conditions. The treatment was injected directly into the salivary glands and was shown to safely decrease saliva production. The goal was to improve comfort and quality of life for people bothered by excessive drooling.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SIALORRHEA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Study site
Loma Linda, California, 92354, United States
-
Study site
Los Angeles, California, 90033, United States
-
Study site
National City, California, 91950, United States
-
Study site
Aurora, Colorado, 80045, United States
-
Study site
Washington D.C., District of Columbia, 20007, United States
-
Study site
Boca Raton, Florida, 33486, United States
-
Study site
Port Charlotte, Florida, 33980, United States
-
Study site
Carmel, Indiana, 46032, United States
-
Study site
Baltimore, Maryland, 21287, United States
-
Study site
Elkridge, Maryland, 21075, United States
-
Study site
Detroit, Michigan, 48334, United States
-
Study site
St Louis, Missouri, 63110, United States
-
Study site
Edison, New Jersey, 08818, United States
-
Study site
Albany, New York, 12208, United States
-
Study site
New York, New York, 10003, United States
-
Study site
Cincinnati, Ohio, 45219, United States
-
Study site
Tulsa, Oklahoma, 74136, United States
-
Study site
Port Royal, South Carolina, 29935, United States
-
Study site
Cordova, Tennessee, 38018, United States
-
Study site
Houston, Texas, 77030, United States
-
Study site
San Antonio, Texas, 78229, United States
-
Study site
Salt Lake City, Utah, 84132, United States
-
Study site
Kirkland, Washington, 98034, United States
-
Study site
Tacoma, Washington, 98409, United States
-
Study site
Irkutsk, Irkutsk Oblast, 664079, Russia
-
Study site
Vsevolozhsk, Leningradskaya Oblast', 188643, Russia
-
Study site
Saint Petersburg, Petrodvorets, 198510, Russia
-
Study site
Krasnoyarsk, 660037, Russia
-
Study site
Dnipropetrovsk, 49027, Ukraine
-
Study site
Ivano-Frankivsk, 76008, Ukraine
-
Study site
Kharkiv, 61068, Ukraine
-
Study site
Lviv, 79010, Ukraine
-
Study site
Rivne, 33010, Ukraine
-
Study site
Uzhhorod, 88018, Ukraine
Conditions
Explore the condition pages connected to this study.